Business intelligence reports for the lab diagnostics industry
Subscribe for Exclusive Access.
Subscriptions & Reports
![Mar2022-DTET-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/Mar2022-DTET-Cover.webp)
![March2022-LCA.Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LCA.Cover_.webp)
![March2022-LIR-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/March2022-LIR-Cover.webp)
![April-2022-NLR-Briefing-Cover](https://g2woo.wpengine.com/wp-content/uploads/2022/03/April-2022-NLR-Briefing-Cover.webp)
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Rapid Diagnostics Play Prominent Role in Federal Plan to Combat Antibiotic Resistance
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies The White House recently unveiled a comprehensive, federal plan to combat the growing threat of antibiotic-resistant bacteria. Diagnostics play a prominent role in the national action plan. The...
CAP, AMP, ASCP and ASCO Welcome Public Comment on Colorectal Cancer Guidelines
By Kelly A. Briganti, Editorial Director, G2 Intelligence Clinical practice guidelines addressing colorectal cancer testing were released for public comment, through the joint efforts of the American Society for Clinical Pathology (ASCP), the College of American...
Rosetta Genomics Obtains Patent for Kidney Cancer Test
By Ron Shinkman, Editor, Laboratory Industry Report New Jersey-based Rosetta Genomics has received a patent for its kidney cancer assay, the company announced this week. Rosetta received a patent for its gene expression test, which can identify four types of kidney...
Rutgers Cancer Institute Teams with Meridian Health for ‘Precision Medicine’ Clinical Trial
By Stephanie Murg, Managing Director, G2 Intelligence Rutgers Cancer Institute of New Jersey (New Brunswick, N.J.) is taking a personalized approach to clinical trials. The National Cancer Institute-designated Comprehensive Cancer Center is partnering with the...